inTEST Co. (NYSE:INTT – Free Report) – Equities researchers at Northland Capmk upped their FY2024 earnings per share (EPS) estimates for shares of inTEST in a report released on Monday, November 4th. Northland Capmk analyst E. Jackson now expects that the company will earn $0.41 per share for the year, up from their prior estimate of $0.35. Northland Capmk has a “Hold” rating on the stock. The consensus estimate for inTEST’s current full-year earnings is $0.35 per share. Northland Capmk also issued estimates for inTEST’s Q4 2024 earnings at $0.14 EPS, Q1 2025 earnings at $0.02 EPS, Q2 2025 earnings at $0.08 EPS, Q3 2025 earnings at $0.11 EPS, Q4 2025 earnings at $0.19 EPS, FY2025 earnings at $0.40 EPS, FY2026 earnings at $0.65 EPS, FY2027 earnings at $0.85 EPS and FY2028 earnings at $1.01 EPS.
Separately, Northland Securities raised their price target on shares of inTEST from $10.00 to $13.00 and gave the stock a “market perform” rating in a research note on Monday.
inTEST Price Performance
Shares of INTT opened at $7.94 on Wednesday. The stock has a market capitalization of $99.41 million, a P/E ratio of 34.52 and a beta of 1.92. inTEST has a twelve month low of $6.28 and a twelve month high of $14.35. The company has a 50 day moving average of $7.05 and a 200-day moving average of $8.75. The company has a quick ratio of 1.46, a current ratio of 2.24 and a debt-to-equity ratio of 0.09.
inTEST (NYSE:INTT – Get Free Report) last issued its quarterly earnings results on Friday, November 1st. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.03. The company had revenue of $30.27 million during the quarter, compared to analysts’ expectations of $32.97 million. inTEST had a net margin of 2.33% and a return on equity of 5.33%.
Institutional Investors Weigh In On inTEST
Several hedge funds have recently added to or reduced their stakes in INTT. Los Angeles Capital Management LLC acquired a new stake in inTEST during the 2nd quarter valued at $1,218,000. Royce & Associates LP lifted its holdings in shares of inTEST by 9.9% during the third quarter. Royce & Associates LP now owns 1,219,157 shares of the company’s stock worth $8,900,000 after buying an additional 110,078 shares in the last quarter. CM Management LLC increased its position in shares of inTEST by 87.5% in the first quarter. CM Management LLC now owns 225,000 shares of the company’s stock worth $2,981,000 after purchasing an additional 105,000 shares during the period. Pacific Ridge Capital Partners LLC increased its position in shares of inTEST by 23.1% in the second quarter. Pacific Ridge Capital Partners LLC now owns 460,914 shares of the company’s stock worth $4,554,000 after purchasing an additional 86,632 shares during the period. Finally, First Eagle Investment Management LLC increased its position in shares of inTEST by 18.0% in the second quarter. First Eagle Investment Management LLC now owns 564,364 shares of the company’s stock worth $5,576,000 after purchasing an additional 86,100 shares during the period. Institutional investors and hedge funds own 63.18% of the company’s stock.
Insider Activity at inTEST
In related news, CEO Richard N. Jr. Grant sold 6,788 shares of the firm’s stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $6.97, for a total value of $47,312.36. Following the completion of the transaction, the chief executive officer now directly owns 164,929 shares of the company’s stock, valued at approximately $1,149,555.13. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 5.50% of the stock is owned by company insiders.
About inTEST
inTEST Corporation provides test and process technology solutions for use in manufacturing and testing in automotive, defense/aerospace, industrial, life sciences, security, and semiconductor markets worldwide. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.
Featured Articles
- Five stocks we like better than inTEST
- How to Invest in the Best Canadian Stocks
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Top Biotech Stocks: Exploring Innovation Opportunities
- Breakout Alert: Qualcomm Just Hit The Rally Button
- P/E Ratio Calculation: How to Assess Stocks
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for inTEST Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for inTEST and related companies with MarketBeat.com's FREE daily email newsletter.